PowerPoint Presentations
 |
||
| 1. | Changing aspects of Clostridium difficile
infection Elisabeth Nagy, Szeged, Hungary |
 |
|
||
| 2. | Immunodefficiency in patients with chronic medical
conditions Galo Peralta, Torrelavega, Spain |
|
|
||
| 3. | The host-microbe interphase as a target for anti-infective
therapy Jordi Vila, Barcelona, Spain |
|
|
||
| 4. | Vaccines for Streptococcus pneumoniae José María Marimón, Donostia-San Sebastián, Spain |
|
|
||
| 5. | Infective endocarditis and surgery Carlos-A. Mestres, Barcelona, Spain |
|
|
||
| 6. | Developments in STDs: global epidemiology and management George Schmid, Geneva, Switzerland |
|
|
||
| 7. | Diagnosis of tuberculosis old and new Achim Schwenk, London, UK |
 |
|
||
| 8. | Innate immunity: the first line against infections Juan Pablo Horcajada, Santander, Spain |
|
|
||
| 9. | Clinical relevance of blood-culture for anaerobes Elisabeth Nagy, Szeged, Hungary |
|
|
||
| 10. | The growing problem of viral respiratory infections Nuria Rabella, Barcelona, Spain |
|
|
||
| 11. | Development of resistance mechanisms in Pseudomonas
aeruginosa Luis Martinez Martinez, Santander, Spain |
|
|
||
| 12. | Type III secretion systems (TTSS) Franciso Garcia-del Portillo, Madrid, Spain |
|
|
||
| 13. | Antimicrobial consumption and impact on resistance Rafael Canton, Madrid, Spain |
|
|
||
Publications
|
||
| 1. | Infections in patients with diabetes mellitus | |
|
||
| 2. | Infections in cirrhosis | |
|
||
| 3. | Clostridium difficile infection and pseudomembranous colitis | |
|
||
| 4. | Toxin production by an emerging strain of Clostridium difficile-associated with outbreaks of severe disease in North America and Europe | |
|
||
| 5. | Clostridium difficile-associated diarrhea in adults | |
|
||
| 6. | Can we afford to do anaerobic cultures and identification?
A positive point of view |
|
|
||
| 7. | Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center | |
|
||
| 8. | Mechanisms of antibiotic resistance in Pseudomonas aeruginosa | |
|
||
| 9. | Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa | |
|
||
| 10. | Viral pneumonia in older adults | |
|
||
| 11. | Type III protein secretion mechanism in mammalian and plant pathogens | |
|
||
| 12. |
Bacterial adhesion and entry into host cells |
|
|
||
| 13. | Human intestinal bacteria as reservoirs for antibiotic resistance genes | |
|
||
| 14. | Pet animals as reservoirs of antimicrobial-resistant bacteria | |
|
||
| 15. | Resistance in the environment | |
|
||
| 16. | Pneumococcal vaccines: an update on current strategies | |
|
||
| 17. | Pneumococcal vaccines | |
|
||
| 18. | Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance | |
|
||
| 19. | Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections | |
|
||
| 20. | Innate immune responses to infection | |
|
||
| 21. | Clinical manifestations of mannan-binding lectin deficiency | |
|
||
| 22. | Growing importance of liver disease in HIV-infected persons | |
|
||
| 23. | Prevention of viral hepatitis in HIV co-infection | |
|
||
| 24. | Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database | |
|
||
| 25. | Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database | |
|
||
| 26. | The use and effect of surgical therapy for prosthetic valve infective endocarditis: A propensity analysis of a multicenter, international cohort | |
|
||
| 27. | The surgical treatment of infective endocarditis: an overview | |
|
||
| 28. | Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update | |
|
||
| 29. | Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations | |
|
||
| 30. | Outpatient antibiotic use in Europe and association with resistance: a cross-national database study | |
|
||
| 31. | Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape | |
|
||
| 32. | The role of integrons in antibiotic resistance gene capture | |
|
||
| 33. | Utility of the antigen-specific interferon-g assay for the management of tuberculosis | |
|
||
| 34. | Clinical diagnosis and management of tuberculosis, and measurements for its prevention and control (Guidelines of Royal College of Physicians, short version) | |
|
||
| 35. | Clinical diagnosis and management of tuberculosis, and measurements for its prevention and control (Guidelines of Royal College of Physicians, full version) | |
|
||
| 36. | Quorum sensing inhibitors: a bargain of effects | |
|
||
| 37. | The bacterial HPr kinase/phosphorylase: A new type of Ser/Thr kinase as antimicrobial target | |
|
||
| 38. | Guide to sexually transmitted disease resources on the internet | |
|
||
| 39. | European STD Guidelines | |
|
||
| 40. | Resistance integrons and super-integrons | |
|
||